Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Synovial Fibroblast Gene Expression in Response to Fibronectin Fragment

ABSTRACT: Synovial Fibroblast Gene Expression in Response to Fibronectin Fragment

PROVIDER: PRJNA1244454 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Synovial Fibroblast Gene Expression in Response to Fibronectin Fragment

Project description:Synovial Fibroblast Gene Expression in Response to Fibronectin Fragment

| PRJNA1244453 | ENA

Transcriptional response of fibronectin fragment treatment in human articular chondrocytes

Project description:Transcriptional response of fibronectin fragment treatment in human articular chondrocytes

| PRJNA631993 | ENA

Transcriptional response of fibronectin fragment treatment in human articular chondrocytes

Project description:Objective: Fibronectin is a matrix protein that is fragmented during cartilage degradation in osteoarthritis (OA). Treatment of chondrocytes with fibronectin fragments (FN-f) has been used to model OA in vitro, but the system has not been fully characterized. This study sought to define the transcriptional response of chondrocytes to FN-f, and directly compare it to responses traditionally observed in OA. Design: Normal human femoral chondrocytes isolated from tissue donors were treated with either FN-f or PBS (control) for 3, 6, or 18 hours. RNA-seq libraries were compared between time-matched FN-f and control samples in order to identify changes in gene expression over time. Differentially expressed genes were compared to a published OA gene set and used for pathway, transcription factor motif, and kinome analysis. Results: FN-f treatment resulted in 3,914 differentially expressed genes over the time course. Genes that are up- or downregulated in OA were significantly up- (p < 0.00001) or downregulated (p < 0.0004) in response to FN-f. Early response genes were involved in proinflammatory pathways, whereas many late response genes were involved in ferroptosis. The promoters of upregulated genes were enriched for NF-?B, AP-1, and IRF motifs. Highly upregulated kinases included CAMK1G, IRAK2, and the uncharacterized kinase DYRK3, while growth factor receptors TGFBR2 and FGFR2 were downregulated. Conclusions: FN-f treatment of normal human articular chondrocytes recapitulated many key aspects of the OA chondrocyte phenotype. This in vitro model is promising for future OA studies, especially considering its compatibility with genomics and genome-editing techniques.

2020-06-18 | GSE150411 | GEO

Transcriptomic effects of TNFa in primary fibroblast-like synovial cell cultures

Project description:Gene expression profiles in synovial biopsies from patients with rheumatoid arthritis (RA) display a high level of plasticity related to disease activity and response to therapy. In order to identify TNFa-dependent genes in ex vivo RA or other synovial biopsies, we generated the present set of data using primary fibroblast-like synovial cell (FLS) cultures incubated overnight in the presence or the absence of TNFa.

2015-10-07 | GSE73764 | GEO

Identification of distinct synovial fibroblast subsets associated with pain and progression of knee osteoarthritis using single-cell RNA sequencing

Project description:Synovial inflammation is associated with pain severity in patients with knee osteoarthritis (OA). The aim here was to determine in a population with knee OA, whether synovial tissue from areas associated with pain exhibited different synovial fibroblast subsets, compared to synovial tissue from sites not associated with pain. A further aim was to compare differences between early and end-stage disease synovial fibroblast subsets. Parapatellar synovitis was significantly associated with the pattern of patient-reported pain in knee OA patients. Synovial tissue from sites of patient-reported pain exhibited a differential transcriptomic phenotype, with distinct synovial fibroblast subsets in early OA and end-stage OA. Functional pathway analysis revealed that synovial tissue and fibroblast subsets from painful sites promoted fibrosis, inflammation and the growth and activity of neurons. The secretome of fibroblasts from early OA painful sites induced neurite outgrowth in dorsal root ganglion neurons. Sites of patient-reported pain in knee OA is associated with a different synovial tissue phenotype and distinct synovial fibroblast subsets. Further interrogation of these fibroblast pathotypes will increase our understanding of the role of synovitis in OA joint pain and provide a rationale for the therapeutic targeting of fibroblast subsets to alleviate pain in patients.

2021-10-20 | GSE176308 | GEO

Effect of BET Inhibitors on Rheumatoid Synovial Fibroblast Cells [RNA-seq]

Project description:We demonstrate that JQ1 inhibits IL1B based RA Synovial Fibroblast activation and proliferation, by inhibiting key BRD2/4 superenhancer genes.

2020-11-12 | GSE148395 | GEO

Effect of BET Inhibitors on Rheumatoid Synovial Fibroblast Cells [ATAC-seq]

Project description:We demonstrate that JQ1 inhibits IL1B based RA Synovial Fibroblast activation and proliferation, by inhibiting key BRD2/4 superenhancer genes.

2020-11-12 | GSE148403 | GEO

Effect of BET Inhibitors on Rheumatoid Synovial Fibroblast Cells [ChIP-seq]

Project description:We demonstrate that JQ1 inhibits IL1B based RA Synovial Fibroblast activation and proliferation, by inhibiting key BRD2/4 superenhancer genes.

2020-11-12 | GSE148399 | GEO

Effect of Schisandrin on Rheumatoid Synovial Fibroblast-like Synoviocytes

Project description:Effect of Schisandrin on Rheumatoid Synovial Fibroblast-like Synoviocytes

| PRJNA847606 | ENA

Effect of BET Inhibitors on Rheumatoid Synovial Fibroblast Cells

Project description:Effect of BET Inhibitors on Rheumatoid Synovial Fibroblast Cells

| PRJNA624142 | ENA